Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Adicet Bio, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- +7 vs. Q1 2026
- Shares held
- 6.11M
- −300.6K (−4.7%) vs. Q1 2026
- Total value
- $52.8M
- +$9.13M (+20.9%) vs. Q1 2026
- New holders
- 13
- 18 more added
- Sold out
- 6
- 9 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACET on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $52.8M |
| Q1 2026 | 49 | $43.7M |
| Q4 2025 | 49 | $56.6M |
| Q3 2025 | 54 | $41.6M |
| Q2 2025 | 49 | $31.5M |
| Q1 2025 | 56 | $42.0M |
| Q4 2024 | 64 | $55.4M |
| Q3 2024 | 64 | $82.3M |
| Q2 2024 | 86 | $77.4M |
| Q1 2024 | 98 | $176.6M |
| Q4 2023 | 77 | $63.0M |
| Q3 2023 | 84 | $48.9M |
| Q2 2023 | 95 | $90.4M |
| Q1 2023 | 107 | $231.3M |
| Q4 2022 | 100 | $375.7M |
| Q3 2022 | 102 | $590.7M |
| Q2 2022 | 101 | $555.9M |
| Q1 2022 | 88 | $660.4M |
| Q4 2021 | 81 | $531.2M |
| Q3 2021 | 58 | $156.1M |
| Q2 2021 | 66 | $218.1M |
| Q1 2021 | 54 | $266.3M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Adicet Bio, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Danske Bank A/S | 1 | $9 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 3 | $26 | 0.00% | +3 | New |
| FMR LLC | 6 | $52 | 0.00% | +6 | New |
| National Bank of Canada | 17 | $146 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 24 | $207 | 0.00% | +5+26.3% | Added |
| Caitong International Asset Management Co., Ltd | 47 | $406 | 0.00% | +44+1,466.7% | Added |
| BNP Paribas Arbitrage, SA | 50 | $432 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 196 | $1.68K | 0.00% | +188+2,350.0% | Added |
| Avion Wealth | 246 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 277 | $2.39K | 0.00% | −1,144−80.5% | Reduced |
| Royal Bank of Canada | 1,701 | $15.0K | 0.00% | +2+0.1% | Added |
| Morgan Stanley | 2,291 | $19.8K | 0.00% | −1,202−34.4% | Reduced |
| Simplex Trading, LLC | 4,814 | $41.6K | 0.00% | +3,421+245.6% | Added |
| Vanguard Global Advisers, LLC | 5,221 | $45.1K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 6,000 | $51.8K | 0.00% | +6,000 | New |
| Jump Financial, LLC | 10,942 | $94.5K | 0.00% | +10,942 | New |
| Axq Capital, LP | 10,991 | $95.0K | 0.01% | +10,991 | New |
| Vontobel Holding Ltd. | 13,776 | $119.0K | 0.00% | −471−3.3% | Reduced |
| Squarepoint Ops LLC | 15,254 | $131.8K | 0.00% | +15,254 | New |
| Occudo Quantitative Strategies LP | 16,636 | $143.7K | 0.01% | +1,536+10.2% | Added |
| Northern Trust Corp | 18,436 | $159.3K | 0.00% | −764−4.0% | Reduced |
| Prelude Capital Management, LLC | 18,550 | $160.3K | 0.01% | +18,550 | New |
| Susquehanna International Group, LLP | 20,650 | $178.4K | 0.00% | +20,650 | New |
| Johnson & Johnson | 22,779 | $196.8K | 0.02% | 00.0% | Unchanged |
| XTX Topco Ltd | 24,284 | $209.8K | 0.00% | +5,158+27.0% | Added |
| Verdad Advisers, LP | 25,200 | $217.7K | 0.21% | +25,200 | New |
| UBS Group AG | 29,817 | $257.6K | 0.00% | −8,551−22.3% | Reduced |
| Dimensional Fund Advisors LP | 31,603 | $273.0K | 0.00% | +20,825+193.2% | Added |
| Quadrature Capital Ltd | 36,193 | $312.7K | 0.00% | +36,193 | New |
| State Street Corp | 36,222 | $313.0K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 38,582 | $333.3K | 0.01% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 50,670 | $437.8K | 0.00% | +336+0.7% | Added |
| Rangeley Capital, LLC | 50,892 | $439.7K | 0.43% | −5,108−9.1% | Reduced |
| Regeneron Pharmaceuticals, Inc. | 60,511 | $522.8K | 0.30% | 00.0% | Unchanged |
| BlackRock, Inc. | 62,126 | $536.8K | 0.00% | +25,541+69.8% | Added |
| Burkehill Global Management, LP | 62,500 | $540.0K | 0.02% | 00.0% | Unchanged |
| Jane Street Group, LLC | 70,561 | $609.6K | 0.00% | +33,477+90.3% | Added |
| Trexquant Investment LP | 78,002 | $673.9K | 0.00% | +34,336+78.6% | Added |
| Marshall Wace, LLP | 79,488 | $686.8K | 0.00% | +79,488 | New |
| Bridgeway Capital Management, LLC | 85,959 | $742.7K | 0.01% | +85,959 | New |
| DAFNA Capital Management LLC | 93,812 | $810.5K | 0.15% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 95,634 | $826.7K | 0.00% | −5,501−5.4% | Reduced |
| Two Sigma Investments, LP | 96,839 | $836.7K | 0.00% | +53,733+124.7% | Added |
| Acadian Asset Management LLC | 124,832 | $1.08M | 0.00% | +6,694+5.7% | Added |
| NEXTBio Capital Management LP | 157,827 | $1.36M | 0.63% | 00.0% | Unchanged |
| Carlyle Group Inc. | 184,295 | $1.59M | 0.02% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 195,514 | $1.69M | 0.01% | +195,514 | New |
| Alyeska Investment Group, L.P. | 203,799 | $1.76M | 0.00% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 245,518 | $2.12M | 1.61% | +23,563+10.6% | Added |
| Renaissance Technologies LLC | 265,945 | $2.30M | 0.00% | +33,354+14.3% | Added |
| Adage Capital Partners GP, L.L.C. | 274,375 | $2.37M | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 343,228 | $2.97M | 0.00% | +6,704+2.0% | Added |
| Citadel Advisors LLC | 432,738 | $3.74M | 0.00% | +50,915+13.3% | Added |
| Franklin Resources Inc | 626,571 | $5.41M | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 844,787 | $7.30M | 0.14% | −183,157−17.8% | Reduced |
| Ra Capital Management, L.P. | 932,624 | $8.06M | 0.07% | −250,000−21.1% | Reduced |
| Woodline Partners LP | 0 | $0 | 0.00% | −313,124−100.0% | Sold out |
| Prosight Management, LP | 0 | $0 | 0.00% | −250,244−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −53,827−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −3,854−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −3,200−100.0% | Sold out |